Northrop Grumman (NOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

22.07.25 15:30 Uhr

Werte in diesem Artikel
Aktien

492,60 EUR -2,60 EUR -0,53%

69,00 EUR -1,00 EUR -1,43%

Indizes

6.584,3 PKT -3,2 PKT -0,05%

For the quarter ended June 2025, Northrop Grumman (NOC) reported revenue of $10.35 billion, up 1.3% over the same period last year. EPS came in at $7.11, compared to $6.36 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $10.06 billion, representing a surprise of +2.94%. The company delivered an EPS surprise of +5.96%, with the consensus EPS estimate being $6.71.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Northrop Grumman performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Sales- Mission Systems: $3.16 billion compared to the $2.9 billion average estimate based on six analysts. The reported number represents a change of +13.9% year over year.Sales- Aeronautics Systems: $3.11 billion versus $3.15 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +5.1% change.Sales- Intersegment eliminations: $-557 million compared to the $-504.63 million average estimate based on six analysts. The reported number represents a change of -7.8% year over year.Sales- Space Systems: $2.65 billion compared to the $2.7 billion average estimate based on six analysts. The reported number represents a change of -25.9% year over year.Sales- Defense Systems: $1.99 billion compared to the $1.86 billion average estimate based on six analysts. The reported number represents a change of +31.6% year over year.Operating income (loss)- Intersegment eliminations: $-76 million compared to the $-71.11 million average estimate based on six analysts.Operating income (loss)- Defense Systems: $253 million compared to the $183.7 million average estimate based on six analysts.Operating income (loss)- Mission Systems: $441 million compared to the $421.42 million average estimate based on six analysts.Operating income (loss)- Space Systems: $280 million compared to the $283.42 million average estimate based on six analysts.Operating income (loss)- Aeronautics Systems: $321 million versus $299.85 million estimated by six analysts on average.Segment operating income adjustment- Unallocated corporate expenses: $143 million versus the five-analyst average estimate of $-45.17 million.Segment operating income adjustment- FAS/CAS operating adjustment: $63 million versus the four-analyst average estimate of $65.27 million.View all Key Company Metrics for Northrop Grumman here>>>Shares of Northrop Grumman have returned +3.1% over the past month versus the Zacks S&P 500 composite's +5.9% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Northrop Grumman Corporation (NOC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Northrop Grumman und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Northrop Grumman

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Northrop Grumman

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Northrop Grumman Corp.

Wer­bung

Analysen zu Northrop Grumman Corp.

DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
29.03.2018Northrop Grumman OverweightBarclays Capital
26.10.2017Northrop Grumman OutperformRBC Capital Markets
12.01.2017Northrop Grumman OutperformRBC Capital Markets
10.11.2016Northrop Grumman OverweightBarclays Capital
06.10.2016Northrop Grumman OutperformRobert W. Baird & Co. Incorporated
DatumRatingAnalyst
19.05.2016Northrop Grumman Sector PerformRBC Capital Markets
02.05.2016Northrop Grumman Equal WeightBarclays Capital
30.04.2015Northrop Grumman NeutralUBS AG
12.02.2015Northrop Grumman Equal WeightBarclays Capital
19.10.2012Northrop Grumman performOppenheimer & Co. Inc.
DatumRatingAnalyst
13.09.2012Northrop Grumman sellUBS AG
14.06.2006Update Northrop Grumman Corp.: UnderperformGoldman Sachs

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Northrop Grumman Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen